Banks - Regional
Compare Stocks
5 / 10Stock Comparison
FRBA vs NBTB vs CHMG vs FUNC vs MNSB
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
FRBA vs NBTB vs CHMG vs FUNC vs MNSB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $388M | $2.35B | $331M | $248M | $176M |
| Revenue (TTM) | $247M | $867M | $140M | $112M | $136M |
| Net Income (TTM) | $44M | $169M | $15M | $25M | $16M |
| Gross Margin | 55.2% | 72.1% | 64.2% | 68.8% | 54.4% |
| Operating Margin | 23.2% | 25.3% | 14.2% | 24.4% | 14.0% |
| Forward P/E | 9.1x | 10.8x | 9.6x | 8.7x | 10.4x |
| Total Debt | $271M | $327M | $5M | $188M | $70M |
| Cash & Equiv. | $302M | $185M | $23M | $78M | $25M |
FRBA vs NBTB vs CHMG vs FUNC vs MNSB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| First Bank (FRBA) | 100 | 206.4 | +106.4% |
| NBT Bancorp Inc. (NBTB) | 100 | 143.9 | +43.9% |
| Chemung Financial C… (CHMG) | 100 | 272.1 | +172.1% |
| First United Corpor… (FUNC) | 100 | 277.5 | +177.5% |
| MainStreet Bancshar… (MNSB) | 100 | 177.2 | +77.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FRBA vs NBTB vs CHMG vs FUNC vs MNSB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FRBA carries the broadest edge in this set and is the clearest fit for valuation efficiency and bank quality.
- PEG 0.73 vs NBTB's 1.53
- NIM 3.5% vs FUNC's 3.0%
- Lower P/E (9.1x vs 9.6x)
- Efficiency ratio 0.3% vs CHMG's 0.5% (lower = leaner)
NBTB is the #2 pick in this set and the best alternative if defensive is your priority.
- Beta 0.89, yield 3.2%, current ratio 1.60x
- 3.2% yield, 12-year raise streak, vs FRBA's 1.5%, (1 stock pays no dividend)
CHMG ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.73, Low D/E 1.9%, current ratio 0.13x
- +54.5% vs FRBA's +8.1%
FUNC is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 7 yrs, beta 0.72, yield 2.2%
- Rev growth 16.9%, EPS growth 40.0%
- 289.2% 10Y total return vs CHMG's 198.0%
- 16.9% NII/revenue growth vs CHMG's -6.5%
MNSB is the clearest fit if your priority is stability.
- Beta 0.66 vs NBTB's 0.89
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.9% NII/revenue growth vs CHMG's -6.5% | |
| Value | Lower P/E (9.1x vs 9.6x) | |
| Quality / Margins | Efficiency ratio 0.3% vs CHMG's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.66 vs NBTB's 0.89 | |
| Dividends | 3.2% yield, 12-year raise streak, vs FRBA's 1.5%, (1 stock pays no dividend) | |
| Momentum (1Y) | +54.5% vs FRBA's +8.1% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs CHMG's 0.5% |
FRBA vs NBTB vs CHMG vs FUNC vs MNSB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FRBA vs NBTB vs CHMG vs FUNC vs MNSB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NBTB leads in 2 of 6 categories
FRBA leads 1 • FUNC leads 1 • CHMG leads 0 • MNSB leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NBTB leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NBTB is the larger business by revenue, generating $867M annually — 7.8x FUNC's $112M. NBTB is the more profitable business, keeping 19.5% of every revenue dollar as net income compared to CHMG's 10.8%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $247M | $867M | $140M | $112M | $136M |
| EBITDAEarnings before interest/tax | $60M | $241M | $22M | $36M | $23M |
| Net IncomeAfter-tax profit | $44M | $169M | $15M | $25M | $16M |
| Free Cash FlowCash after capex | $63M | $225M | $47M | $16M | $13M |
| Gross MarginGross profit ÷ Revenue | +55.2% | +72.1% | +64.2% | +68.8% | +54.4% |
| Operating MarginEBIT ÷ Revenue | +23.2% | +25.3% | +14.2% | +24.4% | +14.0% |
| Net MarginNet income ÷ Revenue | +17.7% | +19.5% | +10.8% | +18.4% | +11.5% |
| FCF MarginFCF ÷ Revenue | +25.4% | +25.2% | +1.4% | +18.2% | +7.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +19.5% | +39.5% | +29.8% | +20.2% | +120.9% |
Valuation Metrics
FRBA leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 8.9x trailing earnings, FRBA trades at a 60% valuation discount to CHMG's 22.0x P/E. Adjusting for growth (PEG ratio), FRBA offers better value at 0.71x vs NBTB's 1.92x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $388M | $2.4B | $331M | $248M | $176M |
| Enterprise ValueMkt cap + debt − cash | $356M | $2.5B | $314M | $357M | $221M |
| Trailing P/EPrice ÷ TTM EPS | 8.86x | 13.53x | 22.01x | 12.12x | 13.36x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.07x | 10.80x | 9.64x | 8.68x | 10.45x |
| PEG RatioP/E ÷ EPS growth rate | 0.71x | 1.92x | — | 1.08x | — |
| EV / EBITDAEnterprise value multiple | 6.22x | 10.35x | 15.73x | 11.52x | 11.58x |
| Price / SalesMarket cap ÷ Revenue | 1.57x | 2.71x | 2.37x | 2.22x | 1.30x |
| Price / BookPrice ÷ Book value/share | 0.87x | 1.21x | 1.30x | 1.39x | 0.82x |
| Price / FCFMarket cap ÷ FCF | 6.19x | 10.75x | 163.62x | 12.18x | 16.57x |
Profitability & Efficiency
Evenly matched — NBTB and FUNC each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
FUNC delivers a 12.5% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $6 for CHMG. CHMG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to FUNC's 1.05x. On the Piotroski fundamental quality scale (0–9), NBTB scores 7/9 vs CHMG's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.2% | +9.5% | +6.3% | +12.5% | +7.3% |
| ROA (TTM)Return on assets | +1.1% | +1.1% | +0.5% | +1.2% | +0.7% |
| ROICReturn on invested capital | +6.1% | +7.9% | +5.0% | +5.9% | +5.0% |
| ROCEReturn on capital employed | +7.8% | +2.4% | +5.6% | +8.5% | +0.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 3 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.61x | 0.17x | 0.02x | 1.05x | 0.32x |
| Net DebtTotal debt minus cash | -$31M | $142M | -$18M | $109M | $45M |
| Cash & Equiv.Liquid assets | $302M | $185M | $23M | $78M | $25M |
| Total DebtShort + long-term debt | $271M | $327M | $5M | $188M | $70M |
| Interest CoverageEBIT ÷ Interest expense | 0.58x | 1.05x | 0.44x | 1.01x | 0.31x |
Total Returns (Dividends Reinvested)
FUNC leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in FUNC five years ago would be worth $23,452 today (with dividends reinvested), compared to $12,056 for MNSB. Over the past 12 months, CHMG leads with a +54.5% total return vs FRBA's +8.1%. The 3-year compound annual growth rate (CAGR) favors FUNC at 47.1% vs MNSB's 6.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -4.0% | +9.3% | +27.0% | +4.4% | +19.4% |
| 1-Year ReturnPast 12 months | +8.1% | +9.0% | +54.5% | +27.8% | +26.4% |
| 3-Year ReturnCumulative with dividends | +75.0% | +54.1% | +108.2% | +218.6% | +21.5% |
| 5-Year ReturnCumulative with dividends | +24.0% | +29.9% | +70.4% | +134.5% | +20.6% |
| 10-Year ReturnCumulative with dividends | +138.3% | +102.2% | +198.0% | +289.2% | +126.9% |
| CAGR (3Y)Annualised 3-year return | +20.5% | +15.5% | +27.7% | +47.1% | +6.7% |
Risk & Volatility
Evenly matched — CHMG and MNSB each lead in 1 of 2 comparable metrics.
Risk & Volatility
MNSB is the less volatile stock with a 0.66 beta — it tends to amplify market swings less than NBTB's 0.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHMG currently trades 97.3% from its 52-week high vs FRBA's 85.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.78x | 0.89x | 0.73x | 0.72x | 0.66x |
| 52-Week HighHighest price in past year | $18.11 | $46.92 | $70.83 | $41.95 | $25.17 |
| 52-Week LowLowest price in past year | $14.21 | $39.20 | $43.20 | $28.00 | $17.86 |
| % of 52W HighCurrent price vs 52-week peak | +85.1% | +96.1% | +97.3% | +91.0% | +93.4% |
| RSI (14)Momentum oscillator 0–100 | 39.1 | 57.3 | 67.4 | 50.6 | 50.4 |
| Avg Volume (50D)Average daily shares traded | 66K | 236K | 10K | 11K | 58K |
Analyst Outlook
NBTB leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FRBA as "Buy", NBTB as "Hold", CHMG as "Hold", FUNC as "Buy", MNSB as "Hold". Consensus price targets imply 10.2% upside for FRBA (target: $17) vs -34.5% for FUNC (target: $25). For income investors, NBTB offers the higher dividend yield at 3.17% vs FRBA's 1.55%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $17.00 | $46.00 | $50.00 | $25.00 | — |
| # AnalystsCovering analysts | 4 | 10 | 7 | 1 | 1 |
| Dividend YieldAnnual dividend ÷ price | +1.5% | +3.2% | +1.9% | +2.2% | — |
| Dividend StreakConsecutive years of raises | 0 | 12 | 0 | 7 | 2 |
| Dividend / ShareAnnual DPS | $0.24 | $1.43 | $1.31 | $0.82 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +2.2% | +0.4% | 0.0% | +1.6% | 0.0% |
NBTB leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). FRBA leads in 1 (Valuation Metrics). 2 tied.
FRBA vs NBTB vs CHMG vs FUNC vs MNSB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FRBA or NBTB or CHMG or FUNC or MNSB a better buy right now?
For growth investors, First United Corporation (FUNC) is the stronger pick with 16.
9% revenue growth year-over-year, versus -6. 5% for Chemung Financial Corporation (CHMG). First Bank (FRBA) offers the better valuation at 8. 9x trailing P/E (9. 1x forward), making it the more compelling value choice. Analysts rate First Bank (FRBA) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FRBA or NBTB or CHMG or FUNC or MNSB?
On trailing P/E, First Bank (FRBA) is the cheapest at 8.
9x versus Chemung Financial Corporation at 22. 0x. On forward P/E, First United Corporation is actually cheaper at 8. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: First Bank wins at 0. 73x versus NBT Bancorp Inc. 's 1. 53x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — FRBA or NBTB or CHMG or FUNC or MNSB?
Over the past 5 years, First United Corporation (FUNC) delivered a total return of +134.
5%, compared to +20. 6% for MainStreet Bancshares, Inc. (MNSB). Over 10 years, the gap is even starker: FUNC returned +289. 2% versus NBTB's +102. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FRBA or NBTB or CHMG or FUNC or MNSB?
By beta (market sensitivity over 5 years), MainStreet Bancshares, Inc.
(MNSB) is the lower-risk stock at 0. 66β versus NBT Bancorp Inc. 's 0. 89β — meaning NBTB is approximately 34% more volatile than MNSB relative to the S&P 500. On balance sheet safety, Chemung Financial Corporation (CHMG) carries a lower debt/equity ratio of 2% versus 105% for First United Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — FRBA or NBTB or CHMG or FUNC or MNSB?
By revenue growth (latest reported year), First United Corporation (FUNC) is pulling ahead at 16.
9% versus -6. 5% for Chemung Financial Corporation (CHMG). On earnings-per-share growth, the picture is similar: MainStreet Bancshares, Inc. grew EPS 210. 0% year-over-year, compared to -36. 9% for Chemung Financial Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FRBA or NBTB or CHMG or FUNC or MNSB?
NBT Bancorp Inc.
(NBTB) is the more profitable company, earning 19. 5% net margin versus 10. 8% for Chemung Financial Corporation — meaning it keeps 19. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NBTB leads at 25. 3% versus 14. 0% for MNSB. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FRBA or NBTB or CHMG or FUNC or MNSB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, First Bank (FRBA) is the more undervalued stock at a PEG of 0. 73x versus NBT Bancorp Inc. 's 1. 53x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, First United Corporation (FUNC) trades at 8. 7x forward P/E versus 10. 8x for NBT Bancorp Inc. — 2. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FRBA: 10. 2% to $17. 00.
08Which pays a better dividend — FRBA or NBTB or CHMG or FUNC or MNSB?
In this comparison, NBTB (3.
2% yield), FUNC (2. 2% yield), CHMG (1. 9% yield), FRBA (1. 5% yield) pay a dividend. MNSB does not pay a meaningful dividend and should not be held primarily for income.
09Is FRBA or NBTB or CHMG or FUNC or MNSB better for a retirement portfolio?
For long-horizon retirement investors, First United Corporation (FUNC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
72), 2. 2% yield, +289. 2% 10Y return). Both have compounded well over 10 years (FUNC: +289. 2%, MNSB: +126. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FRBA and NBTB and CHMG and FUNC and MNSB?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: FRBA is a small-cap deep-value stock; NBTB is a small-cap deep-value stock; CHMG is a small-cap quality compounder stock; FUNC is a small-cap high-growth stock; MNSB is a small-cap deep-value stock. FRBA, NBTB, CHMG, FUNC pay a dividend while MNSB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.